California Emerging Infections Program

Description

The California Emerging Infections Program (CEIP), funded under a cooperative agreement with the U.S. Centers for Disease Control and Prevention (CDC), is one of eleven federally funded Emerging Infections Program (EIP) sites. As part of the EIP network, the CEIP has been an invaluable national resource for surveillance, prevention, and control of emerging infectious diseases since 1994. The local, state, and federal partners who make up CEIP include: the departments of public health of the counties of Alameda, Contra Costa, and San Francisco and of the City of Berkeley; the University of California Berkeley School of Public Health; the U.C. San Francisco School of Medicine; the northern California Kaiser Permanente Health Care organization; the California Department of Health Services Division of Communicable Disease Control; CDC; the U.S. Department of Agriculture (USDA); and the U.S. Food and Drug Administration (FDA). The EIP network aims to be a national resource for surveillance, prevention, and control of emerging infectious diseases. CEIP was initiated in 1994 with Co-Directors Duc Vugia, MD, MPH and Arthur Reingold, MD, Health Program Manager Gretchen Rothrock, MPH, and 7 employees, and now employs over 40.

Project Directory

Legionella

Hepatitis

ABCs

CEIP will continue to provide surveillance and intervention activities concerning infectious disease throughout California and in collaboration with other EIPs throughout the country. This project is being funded by the American Recovery and Reinvestment Act of 2009 (ARRA). The Project Director, Gretchen Rothrock has worked with PHFE for over 12 years and has extensive experience coordinating this program. PHFE will act as the applicant for this proposal and will act as the fiscal sponsor upon receipt of the contract.

Pertussis

HPV

v CJD

Severe Steph Pneumo MSSA

SUDS

Clostridium difficile Surveillance

Training

Supplemental Flu - VRDL

CEIP- ARRA HAI

ARRA HAI

13-Valent Pneumococcal Conjugate Vaccine

Quadrivalent Meningococcal Conjugate Vaccine

Human Papilloma Virus Vaccine

National Antimicrobial Resistance Monito